First Ever Study Explores CBD and Cannabis for COVID Related Anxiety

First ever Study Explores CBD and Cannabis for COVID-19-Related Anxiety – And You Can Be Part of It! The Cannabinoid Anxiety Relief Education Study (C.A.R.E.S.) is a first of its kind anywhere and they need subjects! Researchers at the University of California Irvine will be surveying millions of CBD and cannabis users across the United States in an effort to assess the potential role of cannabinoids in reducing COVID-19-related anxiety, insomnia depression, and more. Dr. Sean Young of UC Irvine talks to Paxton Quigley about the role cannabis and CBD might play in alleviating some of the negative effects people are experiencing as a result of isolation, job loss, and financial insecurity as the pandemic continues to wreak havoc at an alarming rate. So far, at least 207,000 Americans and over a million people worldwide have died from COVID-19. Dr. Young, a professor of emergency medicine and a researcher at UC Irvine, tells us about the large research project he and his colleagues are undertaking, which some of you might want to take part in. “This large-scale research study is especially relevant given high COVID-19 driven anxiety levels nationwide and the many state and local governments which have deemed cannabis businesses ‘essential’ and thus accessible during this time,” says Dr. Young, the lead investigator on the research. The researchers note that millions of Americans are already using CBD and cannabis, yet there is very little controlled research as to their efficacy to treat these conditions. The University of California, Irvine Departments of Emergency Medicine and Informatics are working in partnership with Wholistic Research and Education Foundation on this exciting research project.